Staging and Survival in Gynecologic Malignancies | ||||||
| STAGE | OVARIAN | 5-YEAR SURVIVAL, % | ENDOMETRIAL | 5-YEAR SURVIVAL, % | CERVICAL | 5-YEAR SURVIVAL, % |
|---|---|---|---|---|---|---|
| 0 | - | - | Carcinoma in situ | 100 | ||
| I | Confined to ovary | 88-95 | Confined to corpus | >90 | Confined to uterus | 85 |
| II | Confined to pelvis | 70-80 | Involves corpus and cervix | ∼75 | Invades beyond uterus but not pelvic wall | 65 |
| III | Intraabdominal spread | 25-40 | Extends outside the uterus but not outside the true pelvis | 45-60 | Extends to pelvic wall and/or lower third of vagina, or hydronephrosis | 35 |
| IV | Spread outside abdomen | 17 | Extends outside the true pelvis or involves the bladder or rectum | ∼20 | Invades mucosa of bladder or rectum or extends beyond the true pelvis | 7 |